Literature DB >> 23749816

Tuberculosis vaccines: time to reset the paradigm?

Ajit Lalvani1, Saranya Sridhar, C Fordham von Reyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23749816     DOI： 10.1136/thoraxjnl-2013-203456

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  12 in total

Review 1.  Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.

Authors:  Robert L Hunter
Journal:  Tuberculosis (Edinb)       Date:  2016-01-02       Impact factor: 3.131

2.  Novel vaccine strategies against tuberculosis: a road less travelled.

Authors:  Supriya Pokkali; Sanjay Jain
Journal:  Expert Rev Vaccines       Date:  2013-12       Impact factor: 5.217

3.  Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.

Authors:  Mark T Orr; Gregory C Ireton; Elyse A Beebe; Po-Wei D Huang; Valerie A Reese; David Argilla; Rhea N Coler; Steven G Reed
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

4.  Humoral and lung immune responses to Mycobacterium tuberculosis infection in a primate model of protection.

Authors:  Noton K Dutta; James McLachlan; Smriti Mehra; Deepak Kaushal
Journal:  Trials Vaccinol       Date:  2014-03-13

Review 5.  Harnessing local and systemic immunity for vaccines against tuberculosis.

Authors:  P C L Beverley; S Sridhar; A Lalvani; E Z Tchilian
Journal:  Mucosal Immunol       Date:  2013-11-20       Impact factor: 7.313

Review 6.  The Progress of Therapeutic Vaccination with Regard to Tuberculosis.

Authors:  Pere-Joan Cardona
Journal:  Front Microbiol       Date:  2016-09-28       Impact factor: 5.640

7.  Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.

Authors:  Timothy Lahey; Dominick Laddy; Krystal Hill; Jacqueline Schaeffer; Alison Hogg; James Keeble; Belinda Dagg; Mei Mei Ho; Robert D Arbeit; C Fordham von Reyn
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

8.  A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.

Authors:  Peter C L Beverley; Zsolt Ruzsics; Ariann Hey; Claire Hutchings; Simone Boos; Beatrice Bolinger; Emanuele Marchi; Geraldine O'Hara; Paul Klenerman; Ulrich H Koszinowski; Elma Z Tchilian
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

9.  Correlation of phenotypic profiles using targeted proteomics identifies mycobacterial esx-1 substrates.

Authors:  Matthew M Champion; Emily A Williams; Richard S Pinapati; Patricia A DiGiuseppe Champion
Journal:  J Proteome Res       Date:  2014-08-25       Impact factor: 4.466

10.  EsxA membrane-permeabilizing activity plays a key role in mycobacterial cytosolic translocation and virulence: effects of single-residue mutations at glutamine 5.

Authors:  Qi Zhang; Decheng Wang; Guozhong Jiang; Wei Liu; Qing Deng; Xiujun Li; Wei Qian; Hugues Ouellet; Jianjun Sun
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.